Artificial Intelligence in Digital Genome Market, by Offering (Software and Services), by Technology (Machine Learning and Computer Vision), by Functionality (Genome Sequencing and Gene Editing), by Application (Diagnostics, Drug Discovery & Development,

Artificial Intelligence in Digital Genome Market, by Offering (Software and Services), by Technology (Machine Learning and Computer Vision), by Functionality (Genome Sequencing and Gene Editing), by Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Agriculture & Animal Research, and Other Applications), by End User (Pharmaceutical & Biotech Companies and Research Bodies), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Digital genome is a comprehensive digital set of genetic material that occurs in a cell or an organism. It is a simpler way to gather information concerning chronic diseases and utilized by experts to get a nearer look of genetic disorders. A digital genome acts as a supporter that facilitates instant access to trait sequences to resolve unending custom queries. In genomics artificial intelligence focuses on the use of artificial intelligence (AI) in the development of computer systems that can perform tasks such as mapping genomes. Artificial intelligence and machine learning methods are currently been used to overcome various problems faced by genomics such as annotating genomic sequence elements, identifying splice sites, promoters, enhancers, and positioned nucleosomes.
Market Dynamics
Factors such as key players in the market are focusing on growth strategies such as development in AI tools and collaborations which is expected to drive the growth of the global artificial intelligence in digital genome market over forecast period. For instance, in May 2021, NVIDIA, a U.S. based multinational technology company, had developed new artificial intelligence and genomic sequencing capabilities to help researchers track and treat COVID-19. Moreover, in September 2019, Novartis, an American Swiss multinational pharmaceutical corporation and Microsoft, a U.S. based multinational technology corporation, announced a multiyear alliance which will leverage data & artificial intelligence (AI) to transform how medicines are discovered, developed, and commercialized.
Key features of the study:
This report provides in-depth analysis of the global artificial intelligence in digital genome market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global artificial intelligence in digital genome market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include NVIDIA Corporation, IBM, Microsoft, Fabric Genomics Inc., Verge Genomics, MolecularMatch Inc., SOPHiA GENETICS, PrecisionLife Ltd, BenevolentAI, and Deep Genomics from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global artificial intelligence in digital genome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in digital genome market
Detailed Segmentation:
Global Artificial Intelligence in Digital Genome Market, By Offering:
Software
Services
Global Artificial Intelligence in Digital Genome Market, By Technology:
Machine Learning
Computer Vision
Global Artificial Intelligence in Digital Genome Market, By Functionality:
Genome Sequencing
Gene Editing
Global Artificial Intelligence in Digital Genome Market, By Application:
Diagnostics
Drug Discovery & Development
Precision Medicine
Agriculture & Animal Research
Other Applications
Global Artificial Intelligence in Digital Genome Market, By End User:
Pharmaceutical & Biotech Companies
Research Bodies
Global Artificial Intelligence in Digital Genome Market, By Region:
North America
By Offering
Software
Services
By Technology
Machine Learning
Computer Vision
By Functionality
Genome Sequencing
Gene Editing
By Application
Diagnostics
Drug Discovery & Development
Precision Medicine
Agriculture & Animal Research
Other Applications
By End User
Pharmaceutical & Biotech Companies
Research Bodies
By Country
U.S.
Canada
Latin America
By Offering
Software
Services
By Technology
Machine Learning
Computer Vision
By Functionality
Genome Sequencing
Gene Editing
By Application
Diagnostics
Drug Discovery & Development
Precision Medicine
Agriculture & Animal Research
Other Applications
By End User
Pharmaceutical & Biotech Companies
Research Bodies
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Offering
Software
Services
By Technology
Machine Learning
Computer Vision
By Functionality
Genome Sequencing
Gene Editing
By Application
Diagnostics
Drug Discovery & Development
Precision Medicine
Agriculture & Animal Research
Other Applications
By End User
Pharmaceutical & Biotech Companies
Research Bodies
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Offering
Software
Services
By Technology
Machine Learning
Computer Vision
By Functionality
Genome Sequencing
Gene Editing
By Application
Diagnostics
Drug Discovery & Development
Precision Medicine
Agriculture & Animal Research
Other Applications
By End User
Pharmaceutical & Biotech Companies
Research Bodies
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Offering
Software
Services
By Technology
Machine Learning
Computer Vision
By Functionality
Genome Sequencing
Gene Editing
By Application
Diagnostics
Drug Discovery & Development
Precision Medicine
Agriculture & Animal Research
Other Applications
By End User
Pharmaceutical & Biotech Companies
Research Bodies
By Country
GCC
Israel
Rest of Middle East
Africa
By Offering
Software
Services
By Technology
Machine Learning
Computer Vision
By Functionality
Genome Sequencing
Gene Editing
By Application
Diagnostics
Drug Discovery & Development
Precision Medicine
Agriculture & Animal Research
Other Applications
By End User
Pharmaceutical & Biotech Companies
Research Bodies
By Country
South Africa
Central Africa
North Africa
Company Profiles
NVIDIA Corporation*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
IBM
Microsoft
Fabric Genomics Inc.
Verge Genomics
MolecularMatch Inc.
SOPHiA GENETICS
PrecisionLife Ltd
BenevolentAI
Deep Genomics
“*” marked represents similar segmentation in other categories in the respective section.